Vera Schrauwen-Hinderling
Overview
Explore the profile of Vera Schrauwen-Hinderling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kupriyanova Y, Yurchenko I, Bobrov P, Bartels F, Wierichs S, Jonuscheit M, et al.
BMJ Open Diabetes Res Care
. 2025 Feb;
13(1).
PMID: 39965871
Introduction: The study aimed to assess the effect of COVID-19 on hepatic lipid (HL) content, fibrosis risk, and adiposity in persons with type 2 diabetes. Research Design And Methods: Participants...
2.
Pesta D, Anadol-Schmitz E, Sarabhai T, Op den Kamp Y, Gancheva S, Trinks N, et al.
Sci Adv
. 2025 Jan;
11(1):eadr8849.
PMID: 39742483
The athlete's paradox states that intramyocellular triglyceride accumulation associates with insulin resistance in sedentary but not in endurance-trained humans. Underlying mechanisms and the role of muscle lipid distribution and composition...
3.
Zaharia O, Strassburger K, Knebel B, Binsch C, Kupriyanova Y, Moser C, et al.
Diabetes Metab Syndr
. 2024 Oct;
18(10):103137.
PMID: 39427597
Aims: We examined the association of the G allele in the single-nucleotide polymorphism (SNP) rs738409 in the third exon of patatin-like phospholipase domain-containing 3 gene (PNPLA3) gene, with chronic kidney...
4.
Basset-Sagarminaga J, van de Weijer T, Iozzo P, Schrauwen P, Schrauwen-Hinderling V
Diabetologia
. 2024 Feb;
67(5):958.
PMID: 38388754
No abstract available.
5.
Basset-Sagarminaga J, van de Weijer T, Iozzo P, Schrauwen P, Schrauwen-Hinderling V
Diabetologia
. 2023 Dec;
67(3):407-419.
PMID: 38099962
The liver plays a crucial role in the control of glucose homeostasis and is therefore of great interest in the investigation of the development of type 2 diabetes. Hepatic glucose...
6.
Zaharia O, Antoniou S, Bobrov P, Karusheva Y, Bodis K, Kupriyanova Y, et al.
Diabetes Care
. 2023 Oct;
46(12):2232-2239.
PMID: 37874983
Objective: Diabetes may feature impaired insulin kinetics, which could be aggravated by altered hepatic metabolism and glycemic control. Thus, we examined insulin clearance and its possible determinants in individuals with...
7.
Nienhaus F, Walz M, Rothe M, Jahn A, Pfeiler S, Busch L, et al.
J Cardiovasc Magn Reson
. 2023 Oct;
25(1):54.
PMID: 37784080
Background: Macrophages play a pivotal role in vascular inflammation and predict cardiovascular complications. Fluorine-19 magnetic resonance imaging (F MRI) with intravenously applied perfluorocarbon allows a background-free direct quantification of macrophage...
8.
Saatmann N, Schon M, Zaharia O, Huttasch M, Strassburger K, Trenkamp S, et al.
Liver Int
. 2023 Sep;
44(1):27-38.
PMID: 37697960
Background And Aims: Non-alcoholic fatty liver disease (NAFLD) has been linked to type 2 diabetes (T2D), but also to hypothyroidism. Nevertheless, the relationship between thyroid function and NAFLD in diabetes...
9.
Bodis K, Bombrich M, Schon M, Knebel B, Zaharia O, Bonhof G, et al.
Nutr Metab Cardiovasc Dis
. 2023 Jul;
33(9):1785-1796.
PMID: 37495452
Background And Aims: Increased hepatocellular lipid content (HCL) is linked to insulin resistance, risk of type 2 diabetes and related complications. Conversely, a single-nucleotide polymorphism (TM6SF2; rs58542926) in the transmembrane...
10.
Baechle C, Lang A, Strassburger K, Kuss O, Burkart V, Szendroedi J, et al.
BMJ Open Diabetes Res Care
. 2023 Jul;
11(4).
PMID: 37433698
Introduction: To investigate the associations of a lifestyle score with various cardiovascular risk markers, indicators for fatty liver disease as well as MRI-determined total, subcutaneous and visceral adipose tissue mass...